Avicanna Inc revealed that the National Basketball Players Association (NBPA) has announced a new multi-year partnership with Re+Play, the performance-based wellness and recovery line created by Harrington Wellness, designating Re+Play as an official partner of the NBPA.
It’s a positive development for Avicanna, as the Canadian commercial-stage biopharma company’s technology and formulations are the basis of the Re+Play products, which were developed in partnership with the company’s scientists and Harrington Wellness athletes, trainers, and team doctors.
As previously announced, Avicanna will be earning royalties for its technology, supplying the CBD in the US market in addition to commercializing Re+Play in Canada where the products are already launched on the OCS and Medical Cannabis by Shoppers platforms.
WATCH: Avicanna closes $1.475M in private placement from Emotional Intelligence Ventures
The company said the “landmark multi-year product development plan” brings recovery-promoting technology to the masses, with offerings from topicals, kinesiology tape, and massage guns, among other naturally infused-pain products.
“Re+Play’s partnership with the NBPA will provide consumers with a wealth of trusted, technology-driven products, to help them recover like a pro,” Harrington Wellness CEO and former basketball star Al Harrington said in a statement. “As we move into the next phase of the Re+Play brand with our strategic partners at Amazon, the NBPA, and Walmart, we are excited to once again reimagine how we help athletes of all levels recover from pain with CBD and other innovative technology.”
The first product release from this new partnership is a line of proprietarily formulated recovery creams — developed in partnership with Avicanna, which is focused on the development of cannabinoid-based products.
“It was important that we developed a product that was clearly evidence-based and targeted at improving muscle recovery,” said D. Sanford Kunkel, chief medical officer, at Harrington Wellness & Re+Play. “Through our partnership with Avicanna — we were able to develop our line at its R&D headquarters in the Johnson & Johnson (NYSE:JNJ) Innovation Center, JLABS, giving us a significant competitive product advantage.’’
The new Re+Play product can be purchased at www.replayrecovery.com and will also be available through the Replay Recovery Store at Amazon.com and Walmart.com.
Avicanna believes that its two main business segments related to research and development (R&D) and cultivation, strategically position the company to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and extracts throughout North America, Latin America, Europe, and Asia.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive